0001816829-22-000009.txt : 20220715
0001816829-22-000009.hdr.sgml : 20220715
20220715102827
ACCESSION NUMBER: 0001816829-22-000009
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
ITEM INFORMATION: Investment Company Act Section 3(c)
ITEM INFORMATION: Section 3(c)(7)
FILED AS OF DATE: 20220715
DATE AS OF CHANGE: 20220715
EFFECTIVENESS DATE: 20220715
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: HighVista Biotechnology Opportunities Fund LP
CENTRAL INDEX KEY: 0001816829
IRS NUMBER: 851099620
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-371199
FILM NUMBER: 221084641
BUSINESS ADDRESS:
STREET 1: C/O HIGHVISTA STRATEGIES LLC
STREET 2: 200 CLARENDON STREET, 50TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: (617) 406-6500
MAIL ADDRESS:
STREET 1: C/O HIGHVISTA STRATEGIES LLC
STREET 2: 200 CLARENDON STREET, 50TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0001816829
HighVista Biotechnology Opportunities Fund LP
C/O HIGHVISTA STRATEGIES LLC
200 CLARENDON STREET, 50TH FLOOR
BOSTON
MA
MASSACHUSETTS
02116
(617) 406-6500
DELAWARE
None
None
Limited Partnership
true
2020
N/A
HighVista GP VII Limited Partnership
c/o HighVista Strategies LLC
200 Clarendon Street, 50th Floor
Boston
MA
MASSACHUSETTS
02116
Executive Officer
General Partner of the Issuer.
N/A
HighVista Strategies LLC
200 Clarendon Street
50th Floor
Boston
MA
MASSACHUSETTS
02116
Executive Officer
Investment Manager of the Issuer.
Pooled Investment Fund
Hedge Fund
false
Decline to Disclose
- 06b
- 3C
- 3C.7
true
0001816829-21-000002
2020-07-01
true
true
false
500000
Indefinite
358427023
Indefinite
false
28
0
0
0
false
HighVista Biotechnology Opportunities Fund LP
/s/ Ronald Landen
Ronald Landen
General Counsel and Secretary of the GP of the GP
2022-07-15